Metagen Therapeutics, Inc. is at the forefront of microbiome science, focusing on the development of innovative medical therapies through Fecal Microbiota Transplantation (FMT). The company is pioneering Japan's first "intestinal microbiota bank," which aims to facilitate the nationwide implementation of FMT procedures and advance microbiome therapeutics research. FMT is a medical technique that involves transferring gut microbiota from healthy donors to patients, with the goal of restoring a balanced gut environment. This approach has shown promise in treating various conditions, including gastrointestinal cancers, inflammatory bowel diseases, and neurological disorders like Parkinson's disease. Metagen Therapeutics is actively involved in clinical studies to evaluate the safety and efficacy of FMT in combination with immune checkpoint inhibitors for patients with esophageal and gastric cancers.

In addition to FMT, Metagen Therapeutics is leveraging a novel "reverse translational drug discovery" platform, which enhances the drug development process by confirming the safety and efficacy of microbiome-based therapies through clinical research before commercialization. This method allows for earlier implementation of first-in-human trials, thereby increasing the likelihood of successful clinical outcomes. The company collaborates with esteemed institutions, such as Juntendo University and the National Cancer Center, to conduct rigorous clinical studies and advance the understanding of the gut microbiome's role in health and disease. Through these initiatives, Metagen Therapeutics aims to provide new treatment options and improve patient outcomes in various medical fields.

Japan

Metagen Therapeutics, Inc. is a drug discovery and development company that leverages the power of gut microbiome design cultivated in Metabologenomics, Inc.

We are eager for partnerships in pharmaceutical, healthcare, functional food, and academia that envisions creating future businesses with one of the best microbiome scientist teams.

For inquiries, please contact contact@metagentx.com

Metagen Therapeutics

Company Details